Integra LifeSciences Holdings Corporation (IART)
Automate Your Wheel Strategy on IART
With Tiblio's Option Bot, you can configure your own wheel strategy including IART - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol IART
- Rev/Share 21.2094
- Book/Share 13.5838
- PB 1.0814
- Debt/Equity 1.9388
- CurrentRatio 1.2291
- ROIC -0.1333
- MktCap 1144509652.0
- FreeCF/Share -0.1251
- PFCF -119.606
- PE -2.2437
- Debt/Assets 0.549
- DivYield 0
- ROE -0.3557
- Rating C+
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 5
- P/B Score 4
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Upgrade | IART | Argus | Hold | Buy | -- | -- | March 31, 2025 |
| Upgrade | IART | BTIG Research | Sell | Neutral | -- | -- | Oct. 7, 2024 |
News
Is This the Right Time to Hold Integra Stock in Your Portfolio?
Published: March 26, 2025 by: Zacks Investment Research
Sentiment: Neutral
IART stays on investors' radar courtesy of its strong prospects in the CSS segment and international growth.
Read More
Integra Q4 Earnings Beat Estimates, Revenues Rise Y/Y, Stock Up
Published: March 03, 2025 by: Zacks Investment Research
Sentiment: Positive
IART delivers better-than-expected earnings in the fourth quarter of 2024.
Read More
INTEGRA ALERT: Bragar Eagel & Squire, P.C. is Investigating Integra LifeSciences Holdings Corp. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Published: February 25, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Integra LifeSciences Holdings Corp. (NASDAQ: IART) on behalf of long-term stockholders following a class action complaint that was filed against Integra on September 12, 2023 with a Class Period from March 11, 2019 to May 22, 2023. Our investigation concerns whether the board of directors of Integra have breached their fiduciary duties to the company.
Read More
Integra LifeSciences Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides 2025 Financial Guidance
Published: February 25, 2025 by: GlobeNewsWire
Sentiment: Neutral
PRINCETON, N.J., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART) today reported financial results for the fourth quarter and full year ended December 31, 2024.
Read More
Jan De Witte joins GHO Capital as Operating Partner
Published: February 11, 2025 by: GlobeNewsWire
Sentiment: Neutral
Jan De Witte joins GHO Capital as Operating Partner Former CEO of Integra LifeSciences with significant strategic and operational experience to support GHO Capital's portfolio London, UK – 11 February 2025: Global Healthcare Opportunities, or GHO Capital Partners LLP (“GHO”), the European specialist investor in global healthcare, is pleased to announce the appointment of Jan De Witte as Operating Partner. Jan is an accomplished senior executive with extensive experience leading international growth and transformation for global technology and life sciences companies.
Read More
About Integra LifeSciences Holdings Corporation (IART)
- IPO Date 1995-08-16
- Website https://www.integralife.com
- Industry Medical - Devices
- CEO Mojdeh Poul
- Employees 4396